tetano
Editor, Senior Moderator
Diagnostics (Basel)
. 2022 Feb 21;12(2):549.
doi: 10.3390/diagnostics12020549.
A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis
Adedayo Adeboye[SUP] 1 2 [/SUP], Deya Alkhatib[SUP] 1 [/SUP], Asra Butt[SUP] 3 [/SUP], Neeraja Yedlapati[SUP] 1 4 [/SUP], Nadish Garg[SUP] 5 [/SUP]
Affiliations
Abstract
Viral myocarditis is inflammation of the myocardium secondary to viral infection. The clinical presentation of viral myocarditis is very heterogeneous and can range from nonspecific symptoms of malaise and fatigue in subclinical disease to a more florid presentation, such as acute cardiogenic shock and sudden cardiac death in severe cases. The accurate and prompt diagnosis of viral myocarditis is very challenging. Endomyocardial biopsy is considered to be the gold standard test to confirm viral myocarditis; however, it is an invasive procedure, and the sensitivity is low when myocardial involvement is focal. Cardiac imaging hence plays an essential role in the noninvasive evaluation of viral myocarditis. The current coronavirus disease 2019 (COVID-19) pandemic has generated considerable interest in the use of imaging in the early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related myocarditis. This article reviews the role of various cardiac imaging modalities used in the diagnosis and assessment of viral myocarditis, including COVID-19-related myocarditis.
Keywords: COVID-19-related myocarditis; PET-CT; SPECT; cardiac CT; cardiac magnetic resonance imaging (CMR); echocardiography; viral myocarditis.
. 2022 Feb 21;12(2):549.
doi: 10.3390/diagnostics12020549.
A Review of the Role of Imaging Modalities in the Evaluation of Viral Myocarditis with a Special Focus on COVID-19-Related Myocarditis
Adedayo Adeboye[SUP] 1 2 [/SUP], Deya Alkhatib[SUP] 1 [/SUP], Asra Butt[SUP] 3 [/SUP], Neeraja Yedlapati[SUP] 1 4 [/SUP], Nadish Garg[SUP] 5 [/SUP]
Affiliations
- PMID: 35204637
- DOI: 10.3390/diagnostics12020549
Abstract
Viral myocarditis is inflammation of the myocardium secondary to viral infection. The clinical presentation of viral myocarditis is very heterogeneous and can range from nonspecific symptoms of malaise and fatigue in subclinical disease to a more florid presentation, such as acute cardiogenic shock and sudden cardiac death in severe cases. The accurate and prompt diagnosis of viral myocarditis is very challenging. Endomyocardial biopsy is considered to be the gold standard test to confirm viral myocarditis; however, it is an invasive procedure, and the sensitivity is low when myocardial involvement is focal. Cardiac imaging hence plays an essential role in the noninvasive evaluation of viral myocarditis. The current coronavirus disease 2019 (COVID-19) pandemic has generated considerable interest in the use of imaging in the early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related myocarditis. This article reviews the role of various cardiac imaging modalities used in the diagnosis and assessment of viral myocarditis, including COVID-19-related myocarditis.
Keywords: COVID-19-related myocarditis; PET-CT; SPECT; cardiac CT; cardiac magnetic resonance imaging (CMR); echocardiography; viral myocarditis.